Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call
July 28 2014 - 8:30AM
Avanir Pharmaceuticals, Inc. (Nasdaq:AVNR) will
report financial results for the quarter ended June 30, 2014 after
market close on Tuesday, August 5, 2014. The company will conduct a
conference call and an audio webcast at 1:30 pm Pacific Time (4:30
pm Eastern Time) on the same day.
Conference Call Information: Domestic callers: 1 (877) 474-9503
International callers: +1 (857) 244-7556 Passcode: 33730262
Webcast information: Visit http://www.avanir.com.
A webcast replay will be available on the Avanir Web site for 30
days. A telephone replay will be available for 48 hours following
the conclusion of the call by dialing 1 (888) 286-8010 for domestic
callers, or +1 (617) 801-6888 for international callers, and
entering reservation code 41875741.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company
focused on bringing innovative medicines to patients with central
nervous system disorders of high unmet medical need. As part of our
commitment, we have extensively invested in our pipeline and are
dedicated to advancing medicines that can substantially improve the
lives of patients and their loved ones. For more information about
Avanir, please visit www.avanir.com.
AVANIR® is a registered trademark owned by Avanir
Pharmaceuticals, Inc.
©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.
CONTACT: Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700